BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33533694)

  • 1. Impact of next generation sequencing results on clinical management in patients with hematological disorders.
    Patel BJ; Barot SV; Xie Y; Cook JR; Carraway HE; Hsi ED
    Leuk Lymphoma; 2021 Jul; 62(7):1702-1710. PubMed ID: 33533694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of next-generation sequencing in hematologic malignancies.
    Ramkissoon LA; Montgomery ND
    Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.
    Montes-Moreno S; Routbort MJ; Lohman EJ; Barkoh BA; Kanagal-Shamanna R; Bueso-Ramos CE; Singh RR; Medeiros LJ; Luthra R; Patel KP
    PLoS One; 2018; 13(9):e0204218. PubMed ID: 30222780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
    Maeda T
    Rinsho Ketsueki; 2022; 63(4):302-307. PubMed ID: 35491220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
    Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
    Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing-based panel testing for myeloid neoplasms.
    Kuo FC; Dong F
    Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
    Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
    Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
    Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
    Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
    Northrup V; Maybank A; Carson N; Rahmeh T
    Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
    Shumilov E; Flach J; Pabst T; Fiedler M; Angelillo-Scherrer A; Trümper L; Joncourt R; Kohlmann A; Bacher U
    Crit Rev Oncol Hematol; 2018 Jun; 126():64-79. PubMed ID: 29759569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].
    Xu CS; Li XQ; Liu HX; Li CB; Chen Z; Cai JP; Peng MT
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3204-3208. PubMed ID: 31694113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NGS-based multi-gene panel testing in hematological malignancies: diagnosis and prognostic prediction].
    Tanigawa T; Kataoka K
    Rinsho Ketsueki; 2022; 63(4):294-301. PubMed ID: 35491219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
    Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
    Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
    Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections.
    Yu J; Diaz JD; Goldstein SC; Patel RD; Varela JC; Reyenga C; Smith M; Smith T; Balls J; Ahmad S; Mori S
    Transplant Cell Ther; 2021 Jun; 27(6):500.e1-500.e6. PubMed ID: 33849818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.